JP2023535078A5 - - Google Patents
Info
- Publication number
- JP2023535078A5 JP2023535078A5 JP2023504653A JP2023504653A JP2023535078A5 JP 2023535078 A5 JP2023535078 A5 JP 2023535078A5 JP 2023504653 A JP2023504653 A JP 2023504653A JP 2023504653 A JP2023504653 A JP 2023504653A JP 2023535078 A5 JP2023535078 A5 JP 2023535078A5
- Authority
- JP
- Japan
- Prior art keywords
- complex according
- seq
- antibody
- oligonucleotide
- consecutive nucleotides
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063055749P | 2020-07-23 | 2020-07-23 | |
| US63/055,749 | 2020-07-23 | ||
| US202063069075P | 2020-08-23 | 2020-08-23 | |
| US63/069,075 | 2020-08-23 | ||
| US202163143827P | 2021-01-30 | 2021-01-30 | |
| US63/143,827 | 2021-01-30 | ||
| PCT/US2021/040986 WO2022026152A2 (en) | 2020-07-23 | 2021-07-09 | Muscle targeting complexes and uses thereof for treating myotonic dystrophy |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023535078A JP2023535078A (ja) | 2023-08-15 |
| JP2023535078A5 true JP2023535078A5 (cg-RX-API-DMAC7.html) | 2024-07-18 |
| JP7894355B2 JP7894355B2 (ja) | 2026-07-23 |
Family
ID=80038121
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023504653A Active JP7894355B2 (ja) | 2020-07-23 | 2021-07-09 | 筋緊張性ジストロフィーを処置するための筋標的化複合体およびその使用 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20240016952A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4185383A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JP7894355B2 (cg-RX-API-DMAC7.html) |
| KR (1) | KR20230042713A (cg-RX-API-DMAC7.html) |
| CN (1) | CN116438304A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2021318851A1 (cg-RX-API-DMAC7.html) |
| BR (1) | BR112023001126A8 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3186742A1 (cg-RX-API-DMAC7.html) |
| IL (1) | IL299663A (cg-RX-API-DMAC7.html) |
| MX (1) | MX2023000958A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2022026152A2 (cg-RX-API-DMAC7.html) |
Families Citing this family (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US12370264B1 (en) | 2018-08-02 | 2025-07-29 | Dyne Therapeutics, Inc. | Complexes comprising an anti-transferrin receptor antibody linked to an oligonucleotide and method of delivering oligonucleotide to a subject |
| US11911484B2 (en) | 2018-08-02 | 2024-02-27 | Dyne Therapeutics, Inc. | Muscle targeting complexes and uses thereof for treating myotonic dystrophy |
| US12097263B2 (en) | 2018-08-02 | 2024-09-24 | Dyne Therapeutics, Inc. | Muscle targeting complexes and uses thereof for treating myotonic dystrophy |
| US12018087B2 (en) | 2018-08-02 | 2024-06-25 | Dyne Therapeutics, Inc. | Muscle-targeting complexes comprising an anti-transferrin receptor antibody linked to an oligonucleotide and methods of delivering oligonucleotide to a subject |
| EP3830259A4 (en) | 2018-08-02 | 2022-05-04 | Dyne Therapeutics, Inc. | MUSCLE TARGETED COMPLEXES AND THEIR USES IN THE TREATMENT OF FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY |
| US11168141B2 (en) | 2018-08-02 | 2021-11-09 | Dyne Therapeutics, Inc. | Muscle targeting complexes and uses thereof for treating dystrophinopathies |
| WO2020028832A1 (en) | 2018-08-02 | 2020-02-06 | Dyne Therapeutics, Inc. | Muscle targeting complexes and uses thereof for treating dystrophinopathies |
| WO2021154477A1 (en) | 2020-01-31 | 2021-08-05 | Dyne Therapeutics, Inc. | Anti-transferrin receptor (tfr) antibody and uses thereof |
| US11638761B2 (en) | 2021-07-09 | 2023-05-02 | Dyne Therapeutics, Inc. | Muscle targeting complexes and uses thereof for treating Facioscapulohumeral muscular dystrophy |
| US11771776B2 (en) | 2021-07-09 | 2023-10-03 | Dyne Therapeutics, Inc. | Muscle targeting complexes and uses thereof for treating dystrophinopathies |
| US11969475B2 (en) | 2021-07-09 | 2024-04-30 | Dyne Therapeutics, Inc. | Muscle targeting complexes and uses thereof for treating facioscapulohumeral muscular dystrophy |
| AU2021313058A1 (en) * | 2020-07-23 | 2023-03-30 | Dyne Therapeutics, Inc. | Muscle-targeting complexes and uses thereof |
| US11672872B2 (en) | 2021-07-09 | 2023-06-13 | Dyne Therapeutics, Inc. | Anti-transferrin receptor antibody and uses thereof |
| US11633498B2 (en) | 2021-07-09 | 2023-04-25 | Dyne Therapeutics, Inc. | Muscle targeting complexes and uses thereof for treating myotonic dystrophy |
| KR20230079068A (ko) * | 2020-09-03 | 2023-06-05 | 다인 세라퓨틱스, 인크. | 단백질-올리고뉴클레오티드 복합체의 제조 방법 |
| AU2021414227A1 (en) * | 2020-12-31 | 2023-07-06 | Dyne Therapeutics, Inc. | Muscle targeting complexes and uses thereof for treating myotonic dystrophy |
| WO2023283623A1 (en) | 2021-07-09 | 2023-01-12 | Dyne Therapeutics, Inc. | Muscle targeting complexes and formulations for treating dystrophinopathies |
| US20250249117A1 (en) * | 2022-04-15 | 2025-08-07 | Dyne Therapeutics, Inc. | Dosing of muscle targeting complexes for treating myotonic dystrophy |
| IL316143A (en) | 2022-04-15 | 2024-12-01 | Dyne Therapeutics Inc | Muscle targeting complexes and formulations for the treatment of myotonic dystrophy |
| WO2023201324A1 (en) * | 2022-04-15 | 2023-10-19 | Dyne Therapeutics, Inc. | Muscle targeting complexes and uses thereof for treating myotonic dystrophy |
| US20250352672A1 (en) * | 2022-05-13 | 2025-11-20 | University Of Washington | Method for treatment of myotonic dystrophy combining protein expression and rna interference vector delivery with tissue detargeting |
| WO2025006955A2 (en) * | 2023-06-30 | 2025-01-02 | Ionis Pharmaceuticals, Inc. | Cd29 targeted oligonucleotides and uses thereof |
| KR20260044219A (ko) | 2023-07-21 | 2026-04-01 | 매로우 테라퓨틱스, 인크. | 조혈 세포 표적화 접합체 및 관련 방법 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2011349443B2 (en) * | 2010-12-20 | 2015-12-24 | Genentech, Inc. | Anti-mesothelin antibodies and immunoconjugates |
| US9598496B2 (en) * | 2011-05-09 | 2017-03-21 | Perseus Proteomics Inc. | Antibody capable of specifically recognizing transferrin receptor |
| CA2990785C (en) * | 2015-06-24 | 2024-11-12 | Jcr Pharmaceuticals Co., Ltd. | ANTI-HUMAN TRANSFERRIN RECEPTOR ANTIBODIES CROSSING THE BLOOD-BRAIN BARRIER |
| FR3049951A1 (fr) * | 2016-04-12 | 2017-10-13 | Univ Rabelais Francois | Nouvelles constructions peptidiques et leur utilisation dans le traitement de la toxoplasmose |
| KR20190014525A (ko) * | 2016-05-27 | 2019-02-12 | 애브비 바이오테라퓨틱스 인크. | 면역 조절 단백질과 종양 항원을 결합하는 이중특이적 결합 단백질 |
| CN118638787A (zh) * | 2017-12-06 | 2024-09-13 | 艾维迪提生物科学公司 | 治疗肌萎缩和强直性肌营养不良的组合物和方法 |
| AU2019315593B2 (en) * | 2018-08-02 | 2026-05-21 | Dyne Therapeutics, Inc. | Muscle-targeting complexes and uses thereof |
| EP3829594A4 (en) * | 2018-08-02 | 2022-05-11 | Dyne Therapeutics, Inc. | MUSCLE TARGETING COMPLEXES AND THEIR USES FOR THE TREATMENT OF HYPERTROPHIC CARDIOMYOPATHY |
| CN112955154A (zh) * | 2018-08-02 | 2021-06-11 | 达因疗法公司 | 肌肉靶向复合物及其用于治疗强直性肌营养不良的用途 |
| CN112930193A (zh) * | 2018-08-02 | 2021-06-08 | 达因疗法公司 | 肌肉靶向复合物及其在治疗肌肉萎缩中的用途 |
| IL312067B2 (en) * | 2018-12-21 | 2025-08-01 | Avidity Biosciences Inc | Anti-transferrin receptor antibodies and uses thereof |
-
2021
- 2021-07-09 MX MX2023000958A patent/MX2023000958A/es unknown
- 2021-07-09 WO PCT/US2021/040986 patent/WO2022026152A2/en not_active Ceased
- 2021-07-09 BR BR112023001126A patent/BR112023001126A8/pt unknown
- 2021-07-09 JP JP2023504653A patent/JP7894355B2/ja active Active
- 2021-07-09 KR KR1020237005830A patent/KR20230042713A/ko active Pending
- 2021-07-09 AU AU2021318851A patent/AU2021318851A1/en active Pending
- 2021-07-09 US US18/017,170 patent/US20240016952A1/en active Pending
- 2021-07-09 EP EP21850418.1A patent/EP4185383A4/en active Pending
- 2021-07-09 CA CA3186742A patent/CA3186742A1/en active Pending
- 2021-07-09 IL IL299663A patent/IL299663A/en unknown
- 2021-07-09 CN CN202180064935.4A patent/CN116438304A/zh active Pending